Search
by Baz Hiralal
Subject to regulatory approval, Edwards Wildman Palmer LLP will open an office in Istanbul, forming an alliance with boutique mergers and acquisitions and private equity law firm Ismen. The firms will work on cross-border deals in the Central and Eastern Europe, Middle East and Northern Africa region and other emerging markets. Edwards Wildman partner Ted Cominos is leading the initiative. Ismen is led by partners Tolga Ismen and Arzum Gunalcin.
Providence Equity Partners hired Renée Beaumont as a managing director and global head of business development. Beaumont has worked at Goldman, Sachs & Co. since 2004, most recently as a managing director in the merchant banking division. She led its institutional business development efforts and was previously head of the Americas utility/power and communications investing for the infrastructure fund. Prior to Goldman, Beaumont was a senior corporate associate at Shearman & Sterling LLP.
Healthcare-focused Third Rock Ventures LLC announced four moves.
James Geraghty was added as entrepreneur-in-residence. Geraghty was senior vice president, North America strategy and business development at Sanofi. Before that, he spent 20 years at Genzyme Corp., most recently as senior vice president and an officer. While at Genzyme, he had been president of Genzyme Europe and general manager of the cardiovascular business.
John Maraganore joined the firm as a venture partner in a limited capacity to help guide strategy for the firm and its portfolio companies. Maraganore, CEO of Alnylam Pharmaceuticals Inc., which he joined in 2002, was previously an officer and a member of the management team at Millennium Pharmaceuticals Inc. As senior vice president, strategic product development for Millennium, he was responsible for the product franchises in oncology, cardiovascular, inflammation and metabolic diseases.
Steven Paul, former president of Lilly Research Laboratories of Eli Lilly and Co. and director of the Helen & Robert Appel Institute for Alzheimer's Research at Weill Cornell Medical College, is increasing his capacity as a venture partner.
Daniel Lynch, former CEO of ImClone Systems, who joined Third Rock in 2011 as an entrepreneur-in-residence, was named a venture partner to support the commercial and business development of existing portfolio companies.
Orix Public Finance added Jerry H. Abrahams to its municipal investments team in New York, focusing on the Northeast and mid-Atlantic regions. He was a principal at Captona Partners, the asset management arm of Karbone Inc. Prior to his year there, Abrahams worked at Citigroup Inc. for almost 20 years, most recently as a managing director in the municipal securities division.
J. Andrew Jackson joined the Washington office of Jones Day as a partner in the government regulation practice. Formerly a partner in Dickstein Shapiro LLP's Washington office, Jackson has been a U.S. Department of Justice trial lawyer in False Claims Act and government contract litigation.
Separately, the firm is opening an office in Miami. Pedro A. Jimenez, a partner in the business restructuring and reorganization practice, will be partner-in-charge. Enrique Martin, who recently joined the firm as a partner in the mergers and acquisitions practice, will be the office's administrative partner.
In Sydney, Bill Napier joined Jones Day as a partner in the projects and infrastructure practice after 22 years at Herbert Smith Freehills. He will work alongside John Cooper, who recently joined the firm after 26 years at Allens.
Bennett B. Borden and Jay Brudz joined Drinker Biddle & Reath LLP as partners in the firm's Washington office. They will chair the information governance and electronic discovery practice. They were co-chairs of the e-discovery and information governance section at Williams Mullen.
Earlier, Borden practiced at Gibson Dunn & Crutcher LLP and was senior counsel, legal technology at General Electric Co., where he created and led the corporate discovery center, which supported more than 1,200 lawyers.
J. Andrew Jackson joined the Washington office of Jones Day as a partner in the government regulation practice.
